Telemetry Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-18,700
Closed -$3.31M 74
2020
Q1
$3.31M Buy
18,700
+7,000
+60% +$1.32M 11.57% 1
2019
Q4
$2.24M Hold
11,700
7.45% 2
2019
Q3
$1.97M Buy
+11,700
New +$1.91M 5.68% 6
2018
Q2
Sell
-2,000
Closed -$337K 171
2018
Q1
$337K Buy
+2,000
New +$335K 0.13% 91
2017
Q4
Sell
-4,500
Closed -$922K 160
2017
Q3
$922K Buy
+4,500
New +$1.05M 0.33% 49
2016
Q3
Sell
-3,000
Closed -$693K 133
2016
Q2
$693K Sell
3,000
-18,900
-86% -$4.36M 0.37% 44
2016
Q1
$5.87M Buy
21,900
+13,400
+158% +$3.84M 1.71% 5
2015
Q4
$2.66M Buy
+8,500
New +$2.53M 0.9% 28

Other funds holding AGN

Telemetry Investments's AGN Position: Q2 2020 in Review

Telemetry Investments sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 18,700 shares — an estimated $3.31M sold.

Telemetry Investments first reported a position in AGN in Q4 2015 and held it in 8 quarters. The position peaked at $5.87M in Q1 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Telemetry Investments reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Telemetry Investments sold 18,700 Allergan plc shares in Q2 2020, an estimated $3.31M.
  • Telemetry Investments first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Telemetry Investments's Allergan plc position peaked at $5.87M in Q1 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Telemetry Investments's 13F filing for Q2 2020, filed 14 Aug 2020.